XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Apr. 02, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net earnings/(loss) $ (30,860) $ 21,844
Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities:    
Depreciation and amortization 10,175  
Loss on impairment and abandonment of assets 2,126 5,638
Amortization of financing costs and interest expense 3,900 5,949
(Gain)/loss on disposal of assets 71 (1,403)
Gain on sale-leaseback   (49,639)
Share-based compensation 4,666 1,347
Rights offering and Backstop agreement 18,990
Gain on lease terminations   (93,281)
Deferred income taxes (118)  
Construction allowances from landlords 472 401
Change in operating assets and liabilities:    
Inventories (31,575) (22,650)
Prepaid and other current assets 1,891 (2,952)
Accounts payable (2,689) (42,899)
Accrued liabilities (7,710) 37,295
Operating lease assets and liabilities (5,421) (6,538)
Other liabilities — non-current (2,779) 1,481
Income taxes payable 265
Net cash used in operating activities (57,586) (114,484)
Cash flows from investing activities:    
Capital expenditures (5,164) (2,342)
Proceeds from sale-leaseback   68,566
Proceeds from sale of assets   1,896
Net cash provided by/(used in) investing activities (5,164) 68,120
Cash flows from financing activities:    
Proceeds from borrowings under revolving credit facility 675,171 613,370
Repayments of borrowings under revolving credit facility (633,094) (613,470)
Proceeds from term loan   25,000
Proceeds from Rights Offering   40,000
Proceeds from exercise of employee stock options 459 12
Tax payments related to vested stock awards (63)  
Payments on finance leases (121) (167)
Payment of financing fees   (3,174)
Net cash provided by financing activities 42,352 61,571
Net increase/(decrease) in cash and cash equivalents and restricted cash (20,398) 15,207
Cash and cash equivalents and restricted cash, beginning of period 28,855 46,676
Cash and cash equivalents and restricted cash, end of period $ 8,457 $ 61,883